Pelthos Therapeutics is a biotech company located in New Jersey, United States, which is part of the Healthcare sector, and is traded under the ticker PTHS on the NYSEMKT exchange.
Pelthos Therapeutics stock last closed at $16.50, up 22.22% from the previous day, and has increased 29.92% in one year. It has overperformed other stocks in the Biotechnology industry by 1 percentage points. Pelthos Therapeutics stock is currently +266.67% from its 52-week low of $4.50, and -56.58% from its 52-week high of $38.00.
There are currently 659,585 PTHS shares outstanding. The market capitalization of PTHS is $10.88M. In the last 24 hours, 27,700 PTHS shares were traded.
You will need an online brokerage account to access the NYSEMKT market and buy PTHS stock.
Based on our research, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the best brokerage, you'll need to fill out some personal information so you can buy PTHS today.
Now that you've finished signing up on the highest rated stock app, you need to deposit funds:
Watch the tutorial below for more details depositing funds into your new investment account.
Once you have figured out the best place to buy Pelthos Therapeutics stock, it's very important to evaluate their stock before you invest, so you actually comprehend the risk as well as the upside.
WallStreetZen was built to help everyday investors do more accurate fundamental analysis.
You can see all of the due diligence checks on PTHS's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge PTHS's fair value.
You can access more valuation analysis on PTHS's stock here.
Over the past 12 months, executives and large shareholders at PTHS have bought more shares than they have sold.
Knuettel Francis Ii, CEO Pres. CFO Treas Secty of PTHS, was the latest PTHS insider to buy. They bought $3,395.00 worth of PTHS shares on Sep 13, 2024.
Learn more about who owns PTHS shares here.
No, Pelthos Therapeutics doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
You have two main options:
Press the Open button and your broker will execute your order.
If you need additional info about investing in stocks on eToro, watch the helpful video below:
Now that you own some PTHS shares, you'll want to stay up-to-date on your new shares.
Create a watchlist to track the latest developments regarding your PTHS stock.
To reiterate, here are the 6 steps you need to take to buy Pelthos Therapeutics stock right now:
If you need a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to keep tabs on your investment in Pelthos Therapeutics, create your watchlist below.